Laboratory test services provider, Quest Diagnostics Inc. (NYSE: DGX) expects fiscal third quarter profit to miss analysts’ estimation. The Company cited drop in number of tests ordered during the latter part of the quarter for a downbeat guidance. Quest Diagnostics now expects non-GAAP earnings of $1.02 a share down from its earlier projection of $1.15 [...]
Recent Comments